Artificial intelligence was used to help develop rentosertib, a drug candidate for a rare lung condition, and early data suggests it may also slow biological hallmarks of aging. The drug's maker says the compound shows promise in addressing age-related decline, marking what could be the first practical demonstration of AI-assisted drug discovery yielding a candidate with anti-aging properties. The development underscores AI's growing role in pharmaceutical research, though further clinical trials will be needed to confirm efficacy and safety. Source
OpenAI's chief scientist has warned that no one is prepared for the consequences of artificial intelligence, as the company released GPT-6 Astra, which it describes as its most powerful product to date. The statement signals growing concern within AI's leading labs about the trajectory of capability development outpacing safety measures and policy frameworks. OpenAI has not disclosed specific technical details about GPT-6 Astra's capabilities or performance benchmarks. Source
A $3.2 billion AI data center project involving multiple companies is raising accountability questions about who bears responsibility when problems arise. The complexity of corporate structures behind such mega-projects—spanning infrastructure operators, cloud providers, chip manufacturers, and AI firms—creates ambiguity over liability and oversight. Industry observers say this structural opacity could complicate efforts to enforce safety standards or remediate harms as AI infrastructure scales. Source
Voicebox, a new customer feedback tool, allows people to submit complaints and suggestions by recording voice notes on their phones rather than filling out email surveys or spending time on hold with support staff. The product simplifies feedback collection by eliminating friction from traditional channels, leveraging speech-to-text technology to process submissions at scale. The approach reflects broader moves by customer service platforms to adopt voice-first interfaces as a faster alternative to written feedback. Source
Grindr, a dating app, has agreed to pay £26m to settle claims that it breached UK privacy laws by sharing users' data with third parties, including their HIV status. The long-running legal dispute centered on whether the company adequately disclosed how user information was being handled and sold to advertisers and analytics firms. The settlement represents one of the largest privacy penalty payouts against a social platform in Britain. Source